Clinical Trial Update: 18F-fluciclovine PET/MRI Imaging for the Detection of Tumor Recurrence After Radiation Injury to the Brain

View source ↗

Summary

This clinical trial investigating 18F-fluciclovine PET/MRI imaging for detecting tumor recurrence after radiation injury to the brain has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Malignant Neoplasm
• Intracranial Neoplasm

Drugs mentioned

• 18F-fluciclovine (Axumin) (fluciclovine F-18)

Snippet

Sponsor: Mayo Clinic | Conditions: Metastatic Intracranial Malignant Neoplasm, Recurrent Intracranial Neoplasm | Status: TERMINATED